Performance-enhancing drugs in sport.
This discussion reviews the concept and history of ergogenic aides, the penetration of use in society, some benefit/risk information, drug sources in our society, detection and regulation of these agents, and provides a look to the future. It also examines the role of the clinician/endocrinologist for these patients and uses some cases as examples of drug use among adolescents/teens.
Carpenter
Paul C
PC
Divisions of Endocrinology-Metabolism and Bioinformatics Research, Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street, S.W., Rochester, MN 55905, USA. pccarp@mayo.edu
D000293:Adolescent; D000294:Adolescent Behavior / Q000187:drug effects; D045930:Anabolic Agents / Q000494:pharmacology / Q000600:supply & distribution; D004300:Doping in Sports / Q000331:legislation & jurisprudence / Q000379:methods* / Q000523:psychology; D005544:Forecasting; D006801:Humans; D000297:Psychology, Adolescent; D013256:Steroids / Q000494:pharmacology / Q000600:supply & distribution; D019966:Substance-Related Disorders / Q000523:psychology
D045930:Anabolic Agents; D013256:Steroids